Public Health Institute of Sun Yat-sen University Trials

Public Health Institute of Sun Yat-sen University	Welcome, Profile Billing Logout

Public Health Institute of Sun Yat-sen University

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ling, Li

NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Completed

336

Canada, RoW

Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active Experimental: SHR0302 Dose#2, Core Treatment Placebo Comparator: Placebo, Extension Treatment Active Experimental: SHR0302 Dose#1, Extension Treatment Active Experimental: SHR0302 Dose#2

Reistone Biopharma Company Limited

Atopic Dermatitis

08/22

05/23

NCT04263298: Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Recruiting

210

RoW

Fulvestrant, Experimental group, Capecitabine Oral Product, Active Comparator control group

Herui Yao

Metastatic Breast Cancer

05/25

05/30